NK
Narotam Kumar Juneja
About Narotam Kumar Juneja
Data last updated:
Narotam Kumar Juneja was a Whole-Time Director at Panacea Biotec Pharma Limited (2022–2025), Director at Panacea Biotec Limited (2022–2025) and Additional Director at Magbro Health Care Private Limited (2009–2015). The companies operate in Pharma and Life Sciences.
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Whole-Time Director | 01 Apr 2022 | 2019 | ₹265 Cr (FY 2025) | Active | |
| Director | 01 Apr 2022 | 1984 | ₹585 Cr (FY 2024) | Active | |
| Additional Director | 10 Apr 2009 | 2006 | ₹50.81 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Narotam Kumar Juneja
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Narotam Kumar Juneja
Narotam Kumar Juneja was first appointed on 10 Apr 2009 as Additional Director at Magbro Health Care Private Limited. The most recent appointment on record is 01 Apr 2022 at Panacea Biotec Limited.
Narotam Kumar Juneja held 3 earlier board appointments: Panacea Biotec Pharma Limited (Whole-Time Director, 01 Apr 2022 to 31 Mar 2025); Panacea Biotec Limited (Director, 01 Apr 2022 to 31 Mar 2025); Magbro Health Care Private Limited (Additional Director, 10 Apr 2009 to 25 Mar 2015).